Cargando…

Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway

Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis (MS) and a CD4+ T cell-mediated autoimmune disease. The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is recognized as the major mechanism that regulates the differentiation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dang, Chun, Lu, Yaoheng, Chen, Xingyu, Li, Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076548/ https://www.ncbi.nlm.nih.gov/pubmed/33927721 http://dx.doi.org/10.3389/fimmu.2021.650708

Ejemplares similares

Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism
por: Nan, Yuchen, et al.
Publicado: (2017)

Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis
por: Prado, Carolina, et al.
Publicado: (2018)

Azeliragon ameliorates Alzheimer's disease via the Janus tyrosine kinase and signal transducer and activator of transcription signaling pathway
por: Yang, Lijuan, et al.
Publicado: (2021)

Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System
por: Kubo, Satoshi, et al.
Publicado: (2018)

Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation
por: Ortmann, Robert A, et al.
Publicado: (2000)

Role of Janus kinase 1 and signal transducer and activator of transcription 3 in vitiligo
por: Samaka, Rehab M, et al.
Publicado: (2019)

Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior
por: Kocovski, Pece, et al.
Publicado: (2021)

Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis
por: Park, Byunghyun, et al.
Publicado: (2023)

Role of Janus Kinase/Signal Transducers and Activators of Transcription in the Pathogenesis of Pancreatitis and Pancreatic Cancer
por: Yu, Ji Hoon, et al.
Publicado: (2012)

Local Delivery of Interleukin 4 by Retrovirus-Transduced T Lymphocytes Ameliorates Experimental Autoimmune Encephalomyelitis
por: Shaw, Michael K., et al.
Publicado: (1997)

Adenosine A2A Receptor Signaling in the Immunopathogenesis of Experimental Autoimmune Encephalomyelitis
por: Rajasundaram, Skanda
Publicado: (2018)

Janus kinase inhibitors in autoimmune bullous diseases
por: Huang, Dawei, et al.
Publicado: (2023)

Diazepam Impairs Innate and Adaptive Immune Responses and Ameliorates Experimental Autoimmune Encephalomyelitis
por: Falcón, Cristian R., et al.
Publicado: (2021)

Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia
por: Tichauer, Juan E., et al.
Publicado: (2023)

Immunohistochemical study of janus kinase 1/signal transducer and activator of transcription 3 in psoriasis vulgaris
por: Farag, Azza Gaber Antar, et al.
Publicado: (2019)

Erythropoietin Attenuates Experimental Contrast-Induced Nephrology: A Role for the Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Signaling Pathway
por: Yang, Jia, et al.
Publicado: (2021)

Arctigenin Exerts Neuroprotective Effect by Ameliorating Cortical Activities in Experimental Autoimmune Encephalomyelitis In Vivo
por: Wei, Liangpeng, et al.
Publicado: (2021)

Targeting the Janus Kinase Family in Autoimmune Skin Diseases
por: Howell, Michael D., et al.
Publicado: (2019)

Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
por: Berthier, Celine C., et al.
Publicado: (2009)

The Antiepileptic Drug Valproic Acid Restores T Cell Homeostasis and Ameliorates Pathogenesis of Experimental Autoimmune Encephalomyelitis
por: Lv, Jie, et al.
Publicado: (2012)

Human Commensal Prevotella histicola Ameliorates Disease as Effectively as Interferon-Beta in the Experimental Autoimmune Encephalomyelitis
por: Shahi, Shailesh K., et al.
Publicado: (2020)

Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013)

Baicalin Ameliorates Collagen-Induced Arthritis Through the Suppression of Janus Kinase 1 (JAK1)/Signal Transducer and Activator of Transcription 3 (STAT3) Signaling in Mice
por: Wang, Chunxiao, et al.
Publicado: (2018)

TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis
por: Chyuan, I-Tsu, et al.
Publicado: (2018)

Ras and Signal Transducer and Activator of Transcription (STAT) Are Essential and Sufficient Downstream Components of Janus Kinases in Cell Proliferation
por: Mizuguchi, Rumiko, et al.
Publicado: (2000)

Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2019)

Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19
por: Praveen, D., et al.
Publicado: (2020)

Intracerebral bleeding after Janus-kinase inhibitor baricitinib for COVID-19
por: Finsterer, Josef, et al.
Publicado: (2021)

Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer
por: Kumar, J, et al.
Publicado: (2015)

Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer
por: Kumar, J, et al.
Publicado: (2014)

Leptin receptor signaling via Janus kinase 2/Signal transducer and activator of transcription 3 impacts on ovarian cancer cell phenotypes
por: Kumar, Janani, et al.
Publicado: (2017)

Anticancer Activity of Tubulosine through Suppression of Interleukin-6-Induced Janus Kinase 2/Signal Transducer and Activation of Transcription 3 Signaling
por: Kim, Byung-Hak, et al.
Publicado: (2019)

IL-12p35 Inhibits Neuroinflammation and Ameliorates Autoimmune Encephalomyelitis
por: Choi, Jin Kyeong, et al.
Publicado: (2017)

OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis
por: Sánchez-Fernández, Alba, et al.
Publicado: (2019)

The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis
por: Birkner, Katharina, et al.
Publicado: (2017)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
por: Basler, Michael, et al.
Publicado: (2014)

Amelioration of experimental autoimmune encephalomyelitis by Ishige okamurae
por: Ahn, Meejung, et al.
Publicado: (2018)

Oryeongsan (Goreisan) Ameliorates Experimental Autoimmune Encephalomyelitis
por: Inada, Rino, et al.
Publicado: (2019)

Idiopathic erythema multiforme: Evidence of underlying Janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib
por: Damsky, William, et al.
Publicado: (2016)

Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
por: Bharadwaj, Uddalak, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4g7gdfmv918cqeinmhhalenmvh